摘要

The transcriptional activator p-catenin is the primary mediator of the canonical Wnt/beta-catenin signaling pathway. The aberrant formation of the beta-catenin/T-cell factor (Tcf) complex leads to many cancers and organ fibroses. Selective inhibition of beta-catenin/Tcf protein-protein interactions represents an appealing therapeutic strategy. In this study, two new robust, homogeneous high-throughput assays, AlphaScreen and fluorescence polarization, were established to study beta-catenin/Tcf interactions. These two new assays reproduce native beta-catenin/Tcf interactions, quantify inhibitory potency, and are complementary with each other. The establishment of these two high-throughput screenings enables quick identification of inhibitors of beta-catenin/Tcf protein-protein interactions.

  • 出版日期2012-5-1